GANDEEVA THERAPEUTICS Trademark

Trademark Overview


On Tuesday, July 26, 2022, a trademark application was filed for GANDEEVA THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the GANDEEVA THERAPEUTICS trademark a serial number of 97981258. The federal status of this trademark filing is STATEMENT OF USE - TO EXAMINER as of Thursday, March 5, 2026. This trademark is owned by Gandeeva Therapeutics, Inc.. The GANDEEVA THERAPEUTICS trademark is filed in the Computer & Software Services & Scientific Services and Medical & Beauty Services & Agricultural Services categories with the following description:

Providing medical information in the field of oncology; Providing medical information in the field of protein interactions and aberrant protein function; Providing pharmaceutical information; Medical analysis services for diagnostic and treatment purposes; Providing information in the field of medicine via a website; Providing information in the field of oncology via a website; providing information and commentary in the field of precision medicine

Drug discovery services; Scientific research; Medical oncology research; Scientific study and research in the fields of protein interactions and aberrant protein function; Biological research and analysis; Providing medical and scientific research information; Providing information about medical research via a website; Medical and scientific research in the field of cancer treatment and diagnosis; Medical and scientific research in the field of structural biology, artificial intelligence and machine learning; Software as a service (SaaS) services featuring software for bioinformatics data analysis; Pharmaceutical drug development services; Biochemical research and analysis; Providing information in the field of drug discovery via a website; Providing information in the field of structural biology via a website
gandeeva therapeutics

General Information


Serial Number97981258
Word MarkGANDEEVA THERAPEUTICS
Filing DateTuesday, July 26, 2022
Status748 - STATEMENT OF USE - TO EXAMINER
Status DateThursday, March 5, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, August 1, 2023

Trademark Statements


Indication of Colors claimedColor is not claimed as a feature of the mark.
NOT AVAILABLE"THERAPEUTICS"
Goods and ServicesProviding medical information in the field of oncology; Providing medical information in the field of protein interactions and aberrant protein function; Providing pharmaceutical information; Medical analysis services for diagnostic and treatment purposes; Providing information in the field of medicine via a website; Providing information in the field of oncology via a website; providing information and commentary in the field of precision medicine
Goods and ServicesDrug discovery services; Scientific research; Medical oncology research; Scientific study and research in the fields of protein interactions and aberrant protein function; Biological research and analysis; Providing medical and scientific research information; Providing information about medical research via a website; Medical and scientific research in the field of cancer treatment and diagnosis; Medical and scientific research in the field of structural biology, artificial intelligence and machine learning; Software as a service (SaaS) services featuring software for bioinformatics data analysis; Pharmaceutical drug development services; Biochemical research and analysis; Providing information in the field of drug discovery via a website; Providing information in the field of structural biology via a website
Description of MarkThe mark consists of the words "GANDEEVA THERAPEUTICS" together with an arrowhead design on the left.

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, May 22, 2023
Primary Code042
First Use Anywhere DateFriday, January 17, 2025
First Use In Commerce DateFriday, January 17, 2025

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, May 22, 2023
Primary Code044
First Use Anywhere DateFriday, January 17, 2025
First Use In Commerce DateFriday, January 17, 2025

Trademark Owner History


Party NameGandeeva Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSeattle, WA 98101
US

Party NameGandeeva Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSeattle, WA 98101
US

Trademark Events


Event DateEvent Description
Friday, July 29, 2022NEW APPLICATION ENTERED
Wednesday, August 17, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, August 18, 2022NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, May 11, 2023ASSIGNED TO EXAMINER
Monday, May 22, 2023EXAMINERS AMENDMENT -WRITTEN
Monday, May 22, 2023EXAMINERS AMENDMENT E-MAILED
Monday, May 22, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, May 22, 2023EXAMINER'S AMENDMENT ENTERED
Monday, May 22, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 7, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, June 7, 2023WITHDRAWN FROM PUB - OG REVIEW QUERY
Monday, June 12, 2023PREVIOUS ALLOWANCE COUNT WITHDRAWN
Thursday, June 22, 2023EXAMINERS AMENDMENT -WRITTEN
Thursday, June 22, 2023EXAMINERS AMENDMENT E-MAILED
Thursday, June 22, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, June 22, 2023EXAMINER'S AMENDMENT ENTERED
Thursday, June 22, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 12, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 1, 2023PUBLISHED FOR OPPOSITION
Tuesday, August 1, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 26, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 19, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, March 19, 2024SOU EXTENSION 1 FILED
Tuesday, March 19, 2024SOU EXTENSION 1 GRANTED
Wednesday, March 20, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 22, 2024SOU TEAS EXTENSION RECEIVED
Thursday, August 22, 2024SOU EXTENSION 2 FILED
Thursday, August 22, 2024SOU EXTENSION 2 GRANTED
Thursday, August 22, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 24, 2025SOU TEAS EXTENSION RECEIVED
Tuesday, March 25, 2025SOU EXTENSION 3 FILED
Tuesday, March 25, 2025SOU EXTENSION 3 GRANTED
Tuesday, March 25, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 26, 2025SOU TEAS EXTENSION RECEIVED
Friday, September 26, 2025TEAS REQUEST TO DIVIDE RECEIVED
Friday, September 26, 2025TEAS STATEMENT OF USE RECEIVED
Friday, September 26, 2025SOU EXTENSION 4 FILED
Tuesday, March 3, 2026SOU EXTENSION 4 GRANTED
Wednesday, March 4, 2026NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 4, 2026CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, September 26, 2025DIVISIONAL REQUEST RECEIVED
Thursday, March 5, 2026DIVISIONAL PROCESSING COMPLETE
Friday, September 26, 2025USE AMENDMENT FILED
Thursday, March 5, 2026STATEMENT OF USE PROCESSING COMPLETE